Session Details

u-PAR

Monday, 22 March 2004 14:00 -15:30

Co-Chair Niels Behrendt Finsen Laboratory, RigshospitaletDenmark
Co-Chair Gary G Deng Berlex BiosciencesUnited States

Urokinase-catalysed Cleavage of the Urokinase Receptor
  • Dr Gunilla Høyer-Hansen, Finsen Laboratory, Denmark
  • Vascular Endothelial Growth Factor (VEGF), but not Placental Growth Factor (PlGF) Induces Rapid Pro-uPA Activation and Urokinase Receptor (uPAR) Focusing in Endothelial Cells
  • Dr Gerald W Prager, University of Vienna, Austria
  • uPAR Promotes Macrophage Infiltration into Vascular Wall in ApoE Deficient Mice
  • Gary G Deng, Berlex Biosciences, United States
  • Suppression of uPA Receptor by RNA-Cleaving DNAzymes in Osteosarcoma Cells
  • Zhen Lin, St George Clinical School, The University of New South Wales, Australia
  • Novel Protein Interactors of uPAR Identified by Yeast Two Hybrid Analysis
  • Mr Charles E de Bock, Orthopaedic Research Institute, University of New South Wales, Australia
  • Urokinase Receptor Associates with Ligand-engaged Beta1 Integrins and Regulates Cell Adhesion
  • Ying Wei, University of California at San Francisco, United States